---
figid: PMC4546439__oncotarget-06-13899-g001
figtitle: 'Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened'
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC4546439
filename: oncotarget-06-13899-g001.jpg
figlink: /pmc/articles/PMC4546439/figure/F1/
number: F1
caption: 'GLI inhibition can occur at different levels in the activation process of
  GLI transcriptional output: 1a. Increased proteosomal processing of GLI2 into repressor
  form or GLI1 degradation with HPI-1 or IMQ. 1b. Inhibition of GLI processing into
  its activator form by HPI-2/3, 1c. Inhibition of ciliogenesis and therefore processing
  into the activator form with HPI-4, 1d. Inhibition of GLI2 ciliary accumulation
  and thus activation of of GLI2 by ATO. 2. Inhibition at the level of GLI-DNA binding
  through GANT58, GANT61 or GlaB, 3. Through epigenetic silencing with JQ1 or I-BET151
  and 4. Through indirect inhibition of non-canonical signaling pathways known to
  activate the GLI transcription factors. Abbreviations: CKI, casein kinase 1; GANT,
  Gli-ANTagonist; GlaB, Glabrescione; GLI, Glioma-associated oncogene homologue; GLI-A,
  activator form of GLI; GLI-R, repressor form of GLI; GSK3β, glycogen synthase kinase
  3β; HPI, Hedgehog Pathway Inhibitor; IMQ, imiquimod; P, phosphate; PKA, protein
  kinase A; PTCH1, patched 1; SHH, sonic hedgehog; SMO, smoothened; SUFU, suppressor
  of fused.'
papertitle: 'Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened.'
reftext: Annelies Gonnissen, et al. Oncotarget. 2015 Jun 10;6(16):13899-13913.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.965097
figid_alias: PMC4546439__F1
figtype: Figure
redirect_from: /figures/PMC4546439__F1
ndex: 8dae5012-decb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4546439__oncotarget-06-13899-g001.html
  '@type': Dataset
  description: 'GLI inhibition can occur at different levels in the activation process
    of GLI transcriptional output: 1a. Increased proteosomal processing of GLI2 into
    repressor form or GLI1 degradation with HPI-1 or IMQ. 1b. Inhibition of GLI processing
    into its activator form by HPI-2/3, 1c. Inhibition of ciliogenesis and therefore
    processing into the activator form with HPI-4, 1d. Inhibition of GLI2 ciliary
    accumulation and thus activation of of GLI2 by ATO. 2. Inhibition at the level
    of GLI-DNA binding through GANT58, GANT61 or GlaB, 3. Through epigenetic silencing
    with JQ1 or I-BET151 and 4. Through indirect inhibition of non-canonical signaling
    pathways known to activate the GLI transcription factors. Abbreviations: CKI,
    casein kinase 1; GANT, Gli-ANTagonist; GlaB, Glabrescione; GLI, Glioma-associated
    oncogene homologue; GLI-A, activator form of GLI; GLI-R, repressor form of GLI;
    GSK3β, glycogen synthase kinase 3β; HPI, Hedgehog Pathway Inhibitor; IMQ, imiquimod;
    P, phosphate; PKA, protein kinase A; PTCH1, patched 1; SHH, sonic hedgehog; SMO,
    smoothened; SUFU, suppressor of fused.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - gli
  - gli2a
  - sufu
  - puf60b
  - gli1
  - cki
  - gsk3ba
  - gsk3ab
  - gli3
  - ptch1
  - ptch2
  - smo
  - GLI1
  - GLI2
  - SUFU
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CHKA
  - GSK3A
  - GSK3B
  - GLI3
  - PTCH1
  - SMO
  - SMOX
  - WARS1
  - GANAB
  - AKT1
  - AKT2
  - AKT3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - TGFB1
  - TGFB2
  - TGFB3
  - Cancer
---
